Home > Income Statement > CONCORD BIOTECH

CONCORD BIOTECH
Revenue

    Back to Income Statement
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹1,055 Cr₹1,200 Cr₹1,017 Cr₹853 Cr₹713 Cr

What is the latest Revenue of CONCORD BIOTECH ?

The latest Revenue ratio of CONCORD BIOTECH is ₹1,055 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹1,055 Cr
Mar2025₹1,200 Cr
Mar2024₹1,017 Cr
Mar2023₹853 Cr
Mar2022₹713 Cr

How is Revenue of CONCORD BIOTECH Trending?

Years Revenue % Change
Mar2026 ₹1,055 Cr
-12.10
Mar2025 ₹1,200 Cr
18.01
Mar2024 ₹1,017 Cr
19.20
Mar2023 ₹853 Cr
19.67
Mar2022 ₹713 Cr -

Compare Revenue of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹14,961.5 Cr -0.3% 8.7% -21.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹465,471.0 Cr -0.4% 0.9% 19.6% Stock Analytics
DIVIS LABORATORIES ₹226,631.0 Cr -1.2% 21.1% 29.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,157.0 Cr -2.3% 0.3% 34.8% Stock Analytics
CIPLA ₹118,108.0 Cr 0.7% 1.5% -2% Stock Analytics
DR REDDYS LABORATORIES ₹100,578.0 Cr -0.3% -7.1% -3.9% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

-0.3%

8.7%

-21.4%

SENSEX

-0.4%

0.8%

-3%


You may also like the below Video Courses